ASCO 2017
Melanoma: Long-term response after discontinuation of therapy
In Sunday morning´s oral abstract session on melanoma, Caroline Robert from the Institut Gustave Roussy in Paris presented an update on the KEYNOTE-006 trial including impressive long-term survival data.
